These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6970959)

  • 21. [Clinical and immunological studies on viral hepatitis (author's transl)].
    Toyota J
    Hokkaido Igaku Zasshi; 1978 Sep; 53(5):287-302. PubMed ID: 311328
    [No Abstract]   [Full Text] [Related]  

  • 22. [Immunohistochemical study of hepatitis B and D virus antigens (HBsAg, HBcAg, HDAg) in chronic liver diseases].
    Horváth G; Stotz G; Schaff Z; Tolvaj G; Dávid K
    Orv Hetil; 1996 May; 137(21):1133-8. PubMed ID: 8757107
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Radioimmunological determination of HBeAg/anti-HBe in HBsAg-positive liver diseases and in "healthy" HBsAg carriers].
    Arnold W; Hess G; Dormeyer HH; Gahl G; Hoffmann HG; Knolle J; Schönborn H
    Z Gastroenterol; 1979 Oct; 17(10):704-12. PubMed ID: 118595
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of lymphocytes in percutaneous liver biopsy cores. Different T:B cell ratio in HB sAg-positive and -negative hepatitis.
    Miller DJ; Dwyer JM; Klatskin G
    Gastroenterology; 1977 Jun; 72(6):1199-203. PubMed ID: 323096
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circulating T and B lymphocytes and immunoglobulin containing cells in the liver in chronic active liver disease.
    Aldershvile J; Dietrichson O; Hardt F; Nielsen JO
    Acta Pathol Microbiol Scand C; 1977 Feb; 85(1):26-32. PubMed ID: 320822
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship of HBsAg subtypes with HBeAg/anti-HBe status and chronic liver disease. Part I: Analysis of 1744 HBsAg carriers.
    Shiina S; Fujino H; Uta Y; Tagawa K; Unuma T; Yoneyama M; Ohmori T; Suzuki S; Kurita M; Ohashi Y
    Am J Gastroenterol; 1991 Jul; 86(7):866-71. PubMed ID: 2058629
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatitis B antigens and antibodies in asymptomatic carriers and in chronic liver diseases.
    Nakamura S; Takezawa Y; Sato T; Maeda T; Nakamura M; Kera K
    Tohoku J Exp Med; 1979 May; 128(1):81-7. PubMed ID: 452007
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Histochemical, immunological, electron microscopic study in HBsAg patients with liver diseases and healthy carriers.
    Surrenti C; Anselmucci V; Bianchini G; Casini A; Ramarli D; Salvadori G; Gentilini P
    Acta Hepatogastroenterol (Stuttg); 1979 Oct; 26(5):380-7. PubMed ID: 93381
    [No Abstract]   [Full Text] [Related]  

  • 29. Cell-mediated immune response to liver tissue antigen and hepatitis B surface antigen after infection with hepatitis B virus in humans.
    Tiku ML; Beutner KR; Tiku K; Ogra PL
    J Infect Dis; 1978 Nov; 138(5):587-96. PubMed ID: 712116
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatitis B virus and primary hepatocellular carcinoma: family studies in Korea.
    Hann HW; Kim CY; London WT; Whitford P; Blumberg BS
    Int J Cancer; 1982 Jul; 30(1):47-51. PubMed ID: 6288579
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatitis B virus DNA in mononuclear blood cells. A frequent event in hepatitis B surface antigen-positive and -negative patients with acute and chronic liver disease.
    Pasquinelli C; Lauré F; Chatenoud L; Beaurin G; Gazengel C; Bismuth H; Degos F; Tiollais P; Bach JF; Bréchot C
    J Hepatol; 1986; 3(1):95-103. PubMed ID: 3018075
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunoregulation of the in vitro anti-HBs antibody synthesis in chronic HBsAg carriers and in recently boosted anti-hepatitis B vaccine recipients.
    Barnaba V; Valesini G; Levrero M; Zaccari C; Van Dyke A; Falco M; Musca A; Balsano F
    Clin Exp Immunol; 1985 May; 60(2):259-66. PubMed ID: 3874020
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cellular and humoral immune reactions in chronic active liver disease. I. Lymphocyte subsets in liver biopsies of patients with untreated idiopathic autoimmune hepatitis, chronic active hepatitis B and primary biliary cirrhosis.
    Eggink HF; Houthoff HJ; Huitema S; Gips CH; Poppema S
    Clin Exp Immunol; 1982 Oct; 50(1):17-24. PubMed ID: 6983407
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Liver disease and the e antigen in HBsAg carriers with chronic renal failure.
    Coughlin GP; Van Deth AG; Disney AP; Hay J; Wangel AG
    Gut; 1980 Feb; 21(2):118-22. PubMed ID: 7380332
    [TBL] [Abstract][Full Text] [Related]  

  • 35. T- and B-cell responses and previous exposure to hepatitis B virus in 'anti-HBc alone' patients.
    Wang Q; Sachse P; Semmo M; Lokhande M; Montani M; Dufour JF; Zoulim F; Klenerman P; Semmo N
    J Viral Hepat; 2015 Dec; 22(12):1068-78. PubMed ID: 26075501
    [TBL] [Abstract][Full Text] [Related]  

  • 36. T and B lymphocytes in uremic patients with type B hepatitis infection.
    Tong MJ; Bischel MD; Scoles B; Berne TV
    Nephron; 1977; 18(3):162-6. PubMed ID: 300854
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Circulating immune complexes in HBsAg-positive and HBsAg-negative chronic liver diseases.
    Pastore G; Schena FP; Angarano G; Monno L; Santantonio T; Pertosa G; Schiraldi O
    Ric Clin Lab; 1984; 14(1):29-35. PubMed ID: 6427879
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship between T cell subsets and suppressor cell activity in chronic hepatitis B virus (HBV) infection.
    Barnaba V; Musca A; Cordova C; Levrero M; Ruocco G; Albertini-Petroni V; Balsano F
    Clin Exp Immunol; 1983 Aug; 53(2):281-8. PubMed ID: 6224609
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fibroblast interferon treatment of a patient with chronic active hepatitis. Increased number of circulating T lymphocytes and elimination of rosette-inhibitory factor.
    Dolen JG; Carter WA; Horoszewicz JS; Vladutiu AO; Leibowitz AI; Nolan JP
    Am J Med; 1979 Jul; 67(1):127-31. PubMed ID: 313705
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Minor role of hepatitis B virus in the causation of chronic liver disease in Somalia indicated by a case-control study.
    Bile KM; Abdirahman M; Aden C; Norder H; Magnius L; Lindberg G; Nilsson LH
    Trans R Soc Trop Med Hyg; 1991; 85(1):104-8. PubMed ID: 1712517
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.